<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00589355</url>
  </required_header>
  <id_info>
    <org_study_id>12110</org_study_id>
    <nct_id>NCT00589355</nct_id>
  </id_info>
  <brief_title>C-Reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance</brief_title>
  <official_title>C-Reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine whether markers of vascular inflammation (such as
      c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated
      dilation) in postmenopausal women with glucose intolerance compared to normal controls.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2002</start_date>
  <completion_date type="Anticipated">October 2008</completion_date>
  <primary_completion_date type="Actual">June 2003</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>c-reactive protein</measure>
    <time_frame>performed after screening evaluation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>flow-mediated dilation of brachial artery</measure>
    <time_frame>performed twice after screening visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sex steroids</measure>
    <time_frame>performed after screening visit</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">46</enrollment>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>postmenopausal women with glucose intolerance (either pre-diabetes or diet-controlled diabetes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>postmenopausal women with normal glucose tolerance</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Two groups of healthy postmenopausal women who do not smoke. One group includes women with
        either pre-diabetes or diet-controlled diabetes. The control group includes women with
        normal glucose tolerance
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy postmenopausal women

          -  ages 40-65

        Exclusion Criteria:

          -  smokers

          -  diabetes requiring medication
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara I Gulanski, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale Center for Clinical Investigation</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2007</study_first_submitted>
  <study_first_submitted_qc>December 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2008</study_first_posted>
  <last_update_submitted>December 27, 2007</last_update_submitted>
  <last_update_submitted_qc>December 27, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2008</last_update_posted>
  <responsible_party>
    <name_title>Barbara I Gulanski, MD, MPH</name_title>
    <organization>Yale University School of Medicine</organization>
  </responsible_party>
  <keyword>c-reactive protein</keyword>
  <keyword>endothelial dysfunction</keyword>
  <keyword>glucose intolerance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

